Heart Disease News and Research

Latest Heart Disease News and Research

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Although the incidence of malaria has declined in all but a few countries worldwide, according to a World Health Organization report earlier this month, malaria remains a global threat. Nearly 800,000 people succumbed to the mosquito-borne disease in 2009, nearly all of them in the developing world.

21 Dec 2010

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

AstraZeneca’s new blood thinner that was pitched against Plavix, the world’s second-best selling drug failed to live up to expectations making stocks drop to a two year low, the steepest decline since Nov. 21, 2008, and the worst performance today on the 18-company Bloomberg Europe Pharmaceutical Index.

20 Dec 2010

The health law and legal challenges: What the future holds

News outlets continue their efforts to handicap the health law's chances as it progresses through the judicial system toward the Supreme Court. Meanwhile, The New York Times reports on a proposal — inspired by such repeal efforts — for a Constitutional amendment that would allow states to overturn federal laws passed by Congress.

20 Dec 2010

Health overhaul roundup: Analyzing the individual mandate, watching the politics around reform

While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.

20 Dec 2010

Opsens unveils EasyWire for growth market of Fractional Flow Reserve for coronary lesion assessment

Opsens Inc. today unveiled the EasyWire, developed by its medical division for the growth market of Fractional Flow Reserve for coronary lesion assessment.

20 Dec 2010

Spartan RX CYP2C19 DNA testing system receives European CE Mark certification

Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announced its Spartan RX CYP2C19 received a CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices. The CE Mark certification allows commercial distribution in Europe as well as in all countries recognizing the CE Mark in the Middle East, Africa, Latin America, and Asia-Pacific regions.

20 Dec 2010

Itamar Medical, Roche enter development agreement for EndoPAT device

Itamar Medical, the leader in non-invasive vascular health diagnostics, announced today that an agreement has been signed with Roche by which Itamar will develop an EndoPAT device designated for use with animal models, enabling pre-clinical studies examining the efficacy of various compounds in the early stage of drug development essential for later stage development in humans.

20 Dec 2010

First Edition: December 20, 2010

Today's headlines include more analysis on the continuing legal challenges to the health law and the path they might take to the Supreme Court.

20 Dec 2010

MEDNAX acquires Neonatology Associates in Kingsport

MEDNAX, Inc., today announced the acquisition of a neonatal physician group based in Kingsport, TN.

20 Dec 2010

Response Biomedical strengthens patent protection for RAMP technology

Response Biomedical Corporation today announced that the United States Patent and Trademark Office issued an official Notice of Allowance on one of the Company's patent applications regarding the RAMP® technology. The patent entitled "Comparative Multiple Analyte Immunoassay" is expected to issue in the first quarter of 2011.

20 Dec 2010

VIVUS seeks marketing approval of QNEXA in the EU

VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.

20 Dec 2010

Stereotaxis closes $40 million credit facility

Stereotaxis, Inc. announced today that the Company has closed on its previously announced $40 million credit facility, which includes a $30 million revolving facility that matures on March 31, 2012 and a $10 million term loan that matures on December 31, 2013. The new facility was led by Silicon Valley Bank, and replaces the Company's previous facility that was scheduled to mature in March 2011.

20 Dec 2010

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

With value-based purchasing (VBP) now law under health reform, hospitals participating in the nation's largest hospital VBP demonstration are providing lessons learned that can help others save lives and better craft rules to govern the new program.

20 Dec 2010

Take charge of your medical tests

Whether you're healthy or ill, there are a variety of medical tests your health care team might recommend for you. A yearly checkup often includes routine tests such as blood sugar and cholesterol levels, vision and hearing assessments, tests for heart functioning and others used to monitor a chronic condition—such as a lung function test for those with asthma.

20 Dec 2010

Cardio3 BioSciences presents positive C3BS-GQR-1 results in patients with acute myocardial infarction

Cardio3 BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces positive pre-clinical results from its in-house product candidate C3BS-GQR-1, to treat patients suffering from acute myocardial infarction in order to protect cardiac tissue from damage and direct heart stem cells to mature and restore pump function.

20 Dec 2010

FDA moves to curb Avastin's approval for breast cancer

The Food and Drug administration on Thursday revoked its approval of Roche drug Avastin for the treatment of breast cancer. The agency's action, based on findings that did not confirm that the medicine helped patients with this disease, has drawn criticism from patients and politicians.

20 Dec 2010

$FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF$

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front® Cardiac CryoAblation Catheter system, the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation (PAF). The Cryoballoon treatment involves a minimally-invasive procedure that efficiently creates circumferential lesions around the pulmonary vein, which is the source of erratic electrical signals that cause the irregular heartbeat.

20 Dec 2010

Nanosphere's Verisens cTnI assay measures low levels of troponin I in patients with heart failure

A clinical study released online by the European Journal of Heart Failure, a publication of the European Society of Cardiology, demonstrates the value of using Nanosphere's Verisens cTnI assay to detect very low levels of troponin I in hospitalized patients with heart failure.

20 Dec 2010

SAGE publishes first comprehensive textbook on psychology

Psychology for medicine, published today by SAGE, is the first comprehensive textbook on psychology for medical students that is relevant to all of their undergraduate studies.

20 Dec 2010

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

New research into the health benefits of beetroot juice suggests it's not only athletes who can benefit from its performance enhancing properties - its physiological effects could help the elderly or people with heart or lung-conditions enjoy more active lives.

20 Dec 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

The health law and legal challenges: What the future holds

Health overhaul roundup: Analyzing the individual mandate, watching the politics around reform

Opsens unveils EasyWire for growth market of Fractional Flow Reserve for coronary lesion assessment

Spartan RX CYP2C19 DNA testing system receives European CE Mark certification

Itamar Medical, Roche enter development agreement for EndoPAT device

First Edition: December 20, 2010

MEDNAX acquires Neonatology Associates in Kingsport

Response Biomedical strengthens patent protection for RAMP technology

VIVUS seeks marketing approval of QNEXA in the EU

Stereotaxis closes $40 million credit facility

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

Take charge of your medical tests

Cardio3 BioSciences presents positive C3BS-GQR-1 results in patients with acute myocardial infarction

FDA moves to curb Avastin's approval for breast cancer

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

Nanosphere's Verisens cTnI assay measures low levels of troponin I in patients with heart failure

SAGE publishes first comprehensive textbook on psychology

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in